Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
35.32
-1.68 (-4.54%)
At close: Aug 28, 2026, 4:00 PM EDT
35.40
+0.08 (0.23%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Pharvaris Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Selling, General & Admin | 15.79 | 14.11 | 13.46 | 9.85 | 10.77 | 11.27 | 13.89 | 12.12 | 11.31 | 9.8 | 8.57 | 7.67 | 7.77 | 7.33 | 7.52 | 8.3 | 7.66 | 5.87 | 5.54 | 4.37 |
Research & Development | 35 | 30.16 | 34.14 | 29.81 | 29.61 | 30.91 | 31.2 | 25.78 | 23.07 | 18.51 | 18.61 | 18.54 | 14.68 | 13.74 | 16.05 | 14.09 | 13.72 | 13.51 | 10.7 | 8.96 |
Operating Expenses | 50.79 | 44.27 | 47.6 | 39.66 | 40.37 | 42.19 | 45.09 | 37.9 | 34.38 | 28.31 | 27.18 | 26.2 | 22.46 | 21.08 | 23.57 | 22.39 | 21.38 | 19.38 | 16.24 | 13.33 |
Operating Income | -50.79 | -44.27 | -47.6 | -39.66 | -40.37 | -42.19 | -45.09 | -37.9 | -34.38 | -28.31 | -27.18 | -26.2 | -22.46 | -21.08 | -23.57 | -22.39 | -21.38 | -19.38 | -16.24 | -13.33 |
Interest Expense | - | - | -0.06 | -0.05 | - | - | -0.02 | -0.01 | - | - | - | - | - | - | - | -0.03 | -0.03 | -0.05 | -0.05 | -0.07 |
Interest & Investment Income | 1.98 | 1.67 | 2.19 | 2.15 | 1 | 1.2 | 1.31 | 1.98 | 2.11 | 0.06 | 0.06 | 0.07 | - | 0.11 | 0.09 | - | - | - | - | - |
Currency Exchange Gain (Loss) | 1.64 | 3.76 | 0.39 | 0.24 | -5.87 | -5.02 | 10.28 | -5.55 | 2.62 | 0.52 | -4.88 | 2.69 | 0.67 | -1.6 | -15.39 | 11.52 | 11.54 | 3.44 | 3.92 | 4.33 |
Other Non Operating Income (Expenses) | -0.07 | -0.09 | - | - | -0.04 | -0.03 | - | - | -0.01 | -0.01 | -0.01 | -0 | -0.02 | -0.01 | -0.02 | -0 | -0 | 0 | 0 | -0.01 |
Pretax Income | -47.24 | -38.93 | -45.08 | -37.32 | -45.28 | -46.04 | -33.52 | -41.48 | -29.66 | -27.73 | -32 | -23.45 | -21.8 | -22.57 | -38.89 | -10.89 | -9.88 | -15.99 | -12.36 | -9.08 |
Income Tax Expense | 0.6 | 0.27 | 1.66 | -0.18 | 0.2 | 0.3 | 1.24 | 0.23 | 0.07 | 0.29 | 0.75 | 0.15 | 0.09 | 0.06 | 0.3 | -2.4 | 2.74 | 0.04 | -0.02 | 0.07 |
Net Income | -47.84 | -39.2 | -46.74 | -37.14 | -45.48 | -46.34 | -34.76 | -41.71 | -29.73 | -28.02 | -32.75 | -23.6 | -21.9 | -22.63 | -39.2 | -8.49 | -12.62 | -16.03 | -12.34 | -9.14 |
Net Income to Common | -47.84 | -39.2 | -46.74 | -37.14 | -45.48 | -46.34 | -34.76 | -41.71 | -29.73 | -28.02 | -32.75 | -23.6 | -21.9 | -22.63 | -39.2 | -8.49 | -12.62 | -16.03 | -12.34 | -9.14 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 68 | 65 | 65 | 62 | 55 | 54 | 54 | 54 | 54 | 54 | 44 | 41 | 35 | 34 | 34 | 34 | 34 | 33 | 33 | 33 |
Shares Outstanding (Diluted) | 68 | 65 | 65 | 62 | 55 | 54 | 54 | 54 | 54 | 54 | 44 | 41 | 35 | 34 | 34 | 34 | 34 | 33 | 33 | 33 |
Shares Change (YoY) | 24.47% | 19.85% | 19.88% | 15.14% | 1.39% | 1.38% | 22.91% | 32.17% | 56.09% | 58.90% | 30.70% | 21.09% | 2.90% | 2.03% | 1.96% | 1.98% | 1.38% | 264.12% | 583.85% | - |
EPS (Basic) | -0.70 | -0.60 | -0.72 | -0.60 | -0.83 | -0.85 | -0.64 | -0.77 | -0.55 | -0.52 | -0.74 | -0.58 | -0.63 | -0.67 | -1.16 | -0.25 | -0.38 | -0.48 | -0.37 | -0.28 |
EPS (Diluted) | -0.70 | -0.60 | -0.72 | -0.60 | -0.83 | -0.85 | -0.64 | -0.77 | -0.55 | -0.52 | -0.74 | -0.58 | -0.63 | -0.67 | -1.16 | -0.25 | -0.38 | -0.48 | -0.37 | -0.28 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -37.83 | -48.82 | -37.95 | -30.69 | -29.96 | -38.63 | -35.11 | -33.57 | -27.72 | -24.26 | -23.84 | -23.56 | -20.52 | -25.22 | -20.44 | -15.23 | -13.71 | -17.91 | -12.57 | -10.07 |
Free Cash Flow Per Share | -0.56 | -0.75 | -0.58 | -0.49 | -0.55 | -0.71 | -0.65 | -0.62 | -0.51 | -0.45 | -0.54 | -0.58 | -0.59 | -0.75 | -0.60 | -0.45 | -0.41 | -0.54 | -0.38 | -0.30 |
EBITDA | -50.66 | -44.22 | -47.55 | -39.62 | -40.21 | -42.14 | -45.05 | -37.86 | -34.31 | -28.25 | -27.16 | -26.13 | -22.39 | -21.01 | -23.55 | -22.35 | -21.35 | -19.35 | -16.24 | -13.3 |
D&A For EBITDA | 0.13 | 0.05 | 0.05 | 0.05 | 0.16 | 0.04 | 0.04 | 0.04 | 0.07 | 0.07 | 0.02 | 0.07 | 0.06 | 0.06 | 0.01 | 0.04 | 0.04 | 0.03 | 0 | 0.03 |
EBIT | -50.79 | -44.27 | -47.6 | -39.66 | -40.37 | -42.19 | -45.09 | -37.9 | -34.38 | -28.31 | -27.18 | -26.2 | -22.46 | -21.08 | -23.57 | -22.39 | -21.38 | -19.38 | -16.24 | -13.33 |